Clinicians and policymakers are recognizing the importance of measuring health-related quality of life (HRQL) to inform patient management and policy decisions. Self- or interviewer-administered questionnaires can be used to measure cross-sectional differences in quality of life between patients at a point in time (discriminative instruments) or longitudinal changes in HRQL within patients during a period of time (evaluative instruments). Both discriminative and evaluative instruments must be valid (really measuring what they are supposed to measure) and have a high ratio of signal to noise (reliability and responsiveness, respectively). Reliable discriminative instruments are able to reproducibly differentiate between persons. Responsive evaluative measures are able to detect important changes in HRQL during a period of time, even if those changes are small. Health-related quality of life measures should also be interpretablethat is, clinicians and policymakers must be able to identify differences in scores that correspond to trivial, small, moderate, and large differences.
Two basic approaches to quality-of-life measurement are available: generic instruments that provide a summary of HRQL; and specific instruments that focus on problems associated with single disease states, patient groups, or areas of function. Generic instruments include health profiles and instruments that generate health utilities. The approaches are not mutually exclusive. Each approach has its strengths and weaknesses and may be suitable for different circumstances. Investigations in HRQL have led to instruments suitable for detecting minimally important effects in clinical trials, for measuring the health of populations, and for providing information for policy decisions.
References
- 1. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health. 1990; 11:165-83. Google Scholar
- 2. Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. Oxford University Press. New York, 1993. Google Scholar
- 3. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, et al. How should we measure function in patients with chronic heart and lung disease? J Chron Dis. 1985; 38:517-24. Google Scholar
- 4. Wennberg JE. Outcomes research, cost containment, and the fear of health care rationing. N Engl J Med. 1990; 323:1202-4. Google Scholar
- 5. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986; 5:1-30. Google Scholar
- 6. McCusker J, Stoddart AM. Use of a surrogate for the Sickness Impact Profile. Med Care. 1984; 22:789-95. Google Scholar
- 7. Rothman ML, Hedrick SC, Bulcroft KA, Hickam DH, Rubenstein LZ. The validity of proxy-generated scores as measures of patient health status. Med Care. 1991; 29:115-24. Google Scholar
- 8. Kirshner B, Guyatt GH. A methodologic framework for assessing health indices. J Chronic Dis. 1985; 38:27-36. Google Scholar
- 9. Mossey JM, Shapiro E. Self-rated health: a predictor of mortality among the elderly. Am J Public Health. 1982; 72:800-8. Google Scholar
- 10. Feinstein AR. Clinimetrics. New Haven, Conn.: Yale University Press; 1987:141-66. Google Scholar
- 11. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991; 44:1271-8. Google Scholar
- 12. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987; 42:773-8. Google Scholar
- 13. Bindman AB, Keane D, Lurie N. Measuring health changes among severely ill patients. The floor phenomenon. Med Care. 1990; 28: 1142-52. Google Scholar
- 14. Ganiats TG, Palinkas LA, Kaplan RM. Comparison of Quality of Well-Being Scale and Functional Status Index in patients with atrial fibrillation. Med Care. 1992; 30:958-64. Google Scholar
- 15. Guyatt GH, Mitchell A, Irving EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989; 96:804-10. Google Scholar
- 16. Guyatt GH, Feeny D, Patrick D. Proceedings of the International Conference on the Measurement of Quality of Life as an Outcome in Clinical Trials: Postscript. June 14-17, 1989. Controlled Clin Trials. 1991; 12:266S-269S. Google Scholar
- 17. Jaeschke R, Singer J, Guyatt G. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clin Trials. 1989; 10:407-15. Google Scholar
- 18. Guyatt GH, Townsend M, Pugsley SO, Keller JL, Short HD, Taylor DW, et al. Bronchodilators in chronic airflow limitation, effects on airway function, exercise capacity and quality of life. Am Rev Respir Dis. 1987; 135:1069-74. Google Scholar
- 19. Thompson MS, Read JL, Hutchings HC, Peterson M, Harris ED Jr, et al. The cost effectiveness of auranofin: results of a randomized clinical trial. J Rheumatol. 1988; 15:35-42. Google Scholar
- 20. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981; 19:787-805. Google Scholar
- 21. McSweeney AJ, Grant I, Heaton RK, Adams KM, Timms RM, et al. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982; 142:473-8. Google Scholar
- 22. Fletcher A, McLoone P, Bulpitt C. Quality of life on angina therapy: a randomised controlled trial of transdermal glyceryl trinitrate against placebo. Lancet. 1988; 2:4-8. Google Scholar
- 23. Deyo RA, Inui TS, Leininger JD, Overman SS. Measuring functional outcomes in chronic disease: a comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis. Med Care. 1983; 21:180-92. Google Scholar
- 24. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989; 27:5217-32. Google Scholar
- 25. Boyle MH, Torrance GW, Sinclair JC, Horwood SP. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med. 1983; 308:1330-7. Google Scholar
- 26. Feeny D, Furlong W, Barr RD, Torrance GW, Rosenbaum P, Weitzman S. A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol. 1992; 10:923-8. Google Scholar
- 27. Patrick DL. Health-related quality of life in pharmaceutical evaluation. Forging progress and avoiding pitfalls. PharmacoEconomics. 1992; 1:76-8. Google Scholar
- 28. Laupacis A. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group. Semin Nephrol. 1990; 10(2 Suppl 1):11-9. Google Scholar
- 29. Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986; 314:1657-64. Google Scholar
- 30. Toevs CD, Kaplan RM, Atkins CJ. The costs and effects of behavioral programs in chronic obstructive pulmonary disease. Med Care. 1984; 22:1088-100. Google Scholar
- 31. Gelber RD, Lenderking WR, Cotton DJ, Cole BF, Fischl MA, Goldhirsch A, et al. Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. Ann Intern Med. 1992; 116:961-6. Google Scholar
- 32. Bombardier C, Ware J, Russell IJ, Larson M, Chalmers A, Read JL. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med. 1986; 81:565-78. Google Scholar
- 33. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988; 26:724-35. Google Scholar
- 34. Berkanovic E. The effect of inadequate language translation on Hispanics' responses to health surveys. Am J Public Health. 1980; 70:1273-81. Google Scholar
- 35. Deyo RA. Pitfalls in measuring the health status of Mexican Americans: comparative validity of the English and Spanish Sickness Impact Profile. Am J Public Health. 1984; 74:569-73. Google Scholar
- 36. Nord E. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy. 1991; 18:25-36. Google Scholar
- 37. Spilker B. Quality of life assessments in clinical trials. Raven Press, 1990. Google Scholar
- 38. McDowell I, Newell C. Measuring Health. Oxford University Press, 1987. Google Scholar
- 39. Patrick D, Erickson P. Health status and health policy: quality of life in health care evaluation and resource allocation. New York. Oxford University Press, 1992. Google Scholar
- 40. Feeny D, Guyatt GH, Patrick DL. Proceedings of the International Conference on Quality of Life as an Outcome in Clinical Trials. Controlled Clin Trials. 1991; 12(4 Suppl):79S-280S. Google Scholar
Author, Article, and Disclosure Information
From McMaster University, Hamilton, Ontario, Canada; and the University of Washington, Seattle, Washington.
Corresponding Author: Gordon H. Guyatt, MD, Room 2C12, McMaster University Health Sciences Centre, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.
Grant Support: Dr. Guyatt is a Career Scientist of the Ontario Ministry of Health.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.